295 related articles for article (PubMed ID: 34075200)
41. Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia.
Bhattacharya D; Teramo A; Gasparini VR; Huuhtanen J; Kim D; Theodoropoulos J; Schiavoni G; Barilà G; Vicenzetto C; Calabretto G; Facco M; Kawakami T; Nakazawa H; Falini B; Tiacci E; Ishida F; Semenzato G; Kelkka T; Zambello R; Mustjoki S
Blood Cancer J; 2022 Feb; 12(2):31. PubMed ID: 35210405
[TBL] [Abstract][Full Text] [Related]
42. Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8
Huuhtanen J; Bhattacharya D; Lönnberg T; Kankainen M; Kerr C; Theodoropoulos J; Rajala H; Gurnari C; Kasanen T; Braun T; Teramo A; Zambello R; Herling M; Ishida F; Kawakami T; Salmi M; Loughran T; Maciejewski JP; Lähdesmäki H; Kelkka T; Mustjoki S
Nat Commun; 2022 Apr; 13(1):1981. PubMed ID: 35411050
[TBL] [Abstract][Full Text] [Related]
43. STAT3 mutations are highly specific for large granular lymphocytic leukemia.
Fasan A; Kern W; Grossmann V; Haferlach C; Haferlach T; Schnittger S
Leukemia; 2013 Jul; 27(7):1598-600. PubMed ID: 23207521
[No Abstract] [Full Text] [Related]
44. Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.
Zhu S; Phatarpekar PV; Denman CJ; Senyukov VV; Somanchi SS; Nguyen-Jackson HT; Mace EM; Freeman AF; Watowich SS; Orange JS; Holland SM; Lee DA
Blood; 2014 Jul; 124(3):403-11. PubMed ID: 24891320
[TBL] [Abstract][Full Text] [Related]
45. Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients.
Barilà G; Grassi A; Cheon H; Teramo A; Calabretto G; Chahal J; Vicenzetto C; Almeida J; Shemo BC; Shi M; Gasparini VR; Munoz-Garcia N; Pastoret C; Nakazawa H; Oshimi K; Sokol L; Ishida F; Lamy T; Orfao A; Morice WG; Loughran TP; Semenzato G; Zambello R
Blood; 2023 Mar; 141(9):1036-1046. PubMed ID: 36096473
[TBL] [Abstract][Full Text] [Related]
46. Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation.
Mishra A; Liu S; Sams GH; Curphey DP; Santhanam R; Rush LJ; Schaefer D; Falkenberg LG; Sullivan L; Jaroncyk L; Yang X; Fisk H; Wu LC; Hickey C; Chandler JC; Wu YZ; Heerema NA; Chan KK; Perrotti D; Zhang J; Porcu P; Racke FK; Garzon R; Lee RJ; Marcucci G; Caligiuri MA
Cancer Cell; 2012 Nov; 22(5):645-55. PubMed ID: 23153537
[TBL] [Abstract][Full Text] [Related]
47. Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia.
Johansson P; Bergmann A; Rahmann S; Wohlers I; Scholtysik R; Przekopowitz M; Seifert M; Tschurtschenthaler G; Webersinke G; Jäger U; Siebert R; Klein-Hitpass L; Dührsen U; Dürig J; Küppers R
Int J Cancer; 2016 Jan; 138(1):121-4. PubMed ID: 26199174
[TBL] [Abstract][Full Text] [Related]
48. Clinical relevance of sensitive and quantitative STAT3 mutation analysis using next-generation sequencing in T-cell large granular lymphocytic leukemia.
Kristensen T; Larsen M; Rewes A; Frederiksen H; Thomassen M; Møller MB
J Mol Diagn; 2014 Jul; 16(4):382-92. PubMed ID: 24797340
[TBL] [Abstract][Full Text] [Related]
49. CD8-positive cutaneous lymphoproliferation associated with large granular lymphocyte leukemia in a patient with X-linked agammaglobulinemia.
Daou H; Hatch LA; Weinkle A; Morey GE; Messina J; Zhang X; Sokol L; Seminario-Vidal L
J Cutan Pathol; 2021 Apr; 48(4):567-571. PubMed ID: 32885480
[TBL] [Abstract][Full Text] [Related]
50. Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition.
Quoc Trung L; Espinoza JL; Takami A; Nakao S
PLoS One; 2013; 8(1):e55183. PubMed ID: 23372833
[TBL] [Abstract][Full Text] [Related]
51. A lineage-specific STAT5BN642H mouse model to study NK-cell leukemia.
Klein K; Kollmann S; Hiesinger A; List J; Kendler J; Klampfl T; Rhandawa M; Trifinopoulos J; Maurer B; Grausenburger R; Betram CA; Moriggl R; Rülicke T; Mullighan CG; Witalisz-Siepracka A; Walter W; Hoermann G; Sexl V; Gotthardt D
Blood; 2024 Jun; 143(24):2474-2489. PubMed ID: 38498036
[TBL] [Abstract][Full Text] [Related]
52. A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.
Yokohama A; Mishra A; Mitsui T; Becknell B; Johns J; Curphey D; Blaser BW; Vandeusen JB; Mao H; Yu J; Caligiuri MA
Leuk Res; 2010 Feb; 34(2):203-9. PubMed ID: 19660811
[TBL] [Abstract][Full Text] [Related]
53. Impact of Large Granular Lymphocyte Leukemia on Blood DNA Methylation and Epigenetic Clock Modeling in Fischer 344 Rats.
Finesso GE; McDevitt RA; Roy R; Brinster LR; Di Francesco A; Meade T; de Cabo R; Ferrucci L; Perdue KA
J Gerontol A Biol Sci Med Sci; 2022 May; 77(5):956-963. PubMed ID: 34718551
[TBL] [Abstract][Full Text] [Related]
54. Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia.
Teramo A; Barilà G; Calabretto G; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R
Front Oncol; 2020; 10():152. PubMed ID: 32133291
[TBL] [Abstract][Full Text] [Related]
55. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.
Poullot E; Zambello R; Leblanc F; Bareau B; De March E; Roussel M; Boulland ML; Houot R; Renault A; Fest T; Semenzato G; Loughran T; Lamy T
Ann Oncol; 2014 Oct; 25(10):2030-2035. PubMed ID: 25096606
[TBL] [Abstract][Full Text] [Related]
56. Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma.
Demosthenous C; Han JJ; Hu G; Stenson M; Gupta M
Oncotarget; 2015 Dec; 6(42):44703-13. PubMed ID: 26565811
[TBL] [Abstract][Full Text] [Related]
57. Genomics of LGL leukemia and select other rare leukemia/lymphomas.
Moosic KB; Paila U; Olson KC; Dziewulska K; Wang TT; Xing JC; Ratan A; Feith DJ; Loughran TP; Olson TL
Best Pract Res Clin Haematol; 2019 Sep; 32(3):196-206. PubMed ID: 31585620
[TBL] [Abstract][Full Text] [Related]
58. Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution.
Rivero A; Mozas P; Jiménez L; López-Guerra M; Colomer D; Bataller A; Correa J; Rivas-Delgado A; Bastidas G; Baumann T; Martínez-Trillos A; Delgado J; Giné E; Campo E; López-Guillermo A; Villamor N; Magnano L; Matutes E
Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359799
[TBL] [Abstract][Full Text] [Related]
59. Methylated alteration of SHP1 complements mutation of JAK2 tyrosine kinase in patients with myeloproliferative neoplasm.
Yang JJ; Chen H; Zheng XQ; Li HY; Wu JB; Tang LY; Gao SM
Asian Pac J Cancer Prev; 2015; 16(6):2219-25. PubMed ID: 25824741
[TBL] [Abstract][Full Text] [Related]
60. Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options.
Calabretto G; Teramo A; Barilà G; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R
Cells; 2021 Oct; 10(10):. PubMed ID: 34685780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
